Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT07091721

Using Mentalization Based Therapy to Support Children and Adolescents Referred to Specialist Mental Health Services in the NHS for Aggressive and/or Violent Behaviour

Using Mentalization Based Therapy to Support Children and Adolescents Referred to Specialist Mental Health Services in the NHS for Aggressive and/or Violent Behaviour — Recruiting • Non-phase study…

📅 08 May 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07091721
Sponsor
Anna Freud
Start
2025-12-03
ClinicaliQ Trial Snapshot
  • Using Mentalization Based Therapy to Support Children and Adolescents Referred to Specialist Mental Health Services in the NHS for Aggressive and/or Violent Behaviour — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07091721.
  • What is being tested: The MICA Study evaluates the effectiveness of mentalization-based therapy (MBT)—a psychological intervention that helps young people understand their own thoughts, feelings, and behaviours—as a treatment for children and adolescents presenting with aggressive and/or violent behaviour in NHS specialist….
  • Patient eligibility overview: The trial includes children and adolescents referred to specialist NHS mental health services specifically for aggressive and/or violent behaviour presentations, representing a clinical population with significant functional impairment and risk.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The MICA Study is a research project that has been designed to work out how helpful mentalisation based therapy is. This is a new type of support that helps young people make sense of their own behaviours and feelings, and those of others. It involves meeting regularly with a mental health practitioner and parents/carers can be involved in some meetings too. It is hoped that this new type of support will help young people stop acting aggressively/violently. This project will be delivered in Forensic Child and Adolescent Mental Health Services…

Eligibility Snapshot
  • : * Age 10-17 years at the time of referral; * Aggression and/or violence are indicated at referral or assessment; * Participation in the evaluation would not interfere with statutory orders; * Child and parent/carer (for children 10-15 years) are able to consent and engage with the study materials; * Living in the community at time of referral and no imminent plans to move to hospital, residential, or secure settings. Additional inclusion criteria for participants recruited from a clinician's existing caseload: * There has been no direct contact between child and FCAMHS clinicians, including assessments. * There has been no indirect therapeutic support provided by FCAMHS e.g. advising non-FCAMHS professionals on therapeutic support. * It is permissible for the clinician to have previously engaged in consultation activities where these did not involve contact with the child.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Digital technologies to support self-management of asthma: early-use assessment
Respiratory / COPD / Asthma · 05 May 2026
Use digital asthma self-management tools (apps, web platforms, wearables) as adjuncts to standard care to help patients monitor symptoms, track triggers, and…
View guideline →
Clinical Brief
‘I gave up my job due to the stress of my child’s food allergies’
Respiratory / COPD / Asthma · BBC Health · 23 Apr 2026
Parental burden of food allergies: Severe childhood food allergies can create such significant psychological stress that parents may feel compelled to leave…
View brief →
Guideline
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment
Respiratory / COPD / Asthma · 02 Apr 2026
Digital spirometry algorithms can improve diagnostic accuracy for asthma and COPD in primary care and community diagnostic centres, potentially reducing unnecessary referrals…
View guideline →
Guideline
GINA 2024 Report: Global Strategy for Asthma Management and Prevention
Respiratory / COPD / Asthma · 31 Mar 2026
GINA 2024 reinforces no SABA-only treatment for any asthma severity: all patients should receive ICS-containing controller therapy or ICS-formoterol MART as first-line…
View guideline →
Guideline
2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia
Respiratory / COPD / Asthma · 30 Mar 2026
This ESCMID guideline addresses 2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia in Respiratory / COPD / Asthma. Use it to…
View guideline →
Clinical Brief
Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
Respiratory / COPD / Asthma · MHRA · 24 Apr 2025
Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with…
View brief →